Skip to main content
Year archive

Theranexus — 2018 filings

All 21 regulatory filings released by Theranexus (ALTHX) in 2018, sourced directly from the official regulator.

21 Filings
2018 Period
2018 filings (21)
Filing Released Lang
THERANEXUS ANNONCE L'ARRIVÉE DE MONSIEUR JÉRÔME MARTINEZ AU SEIN DE SON CONSEIL D'ADMINISTRATION
Board/Management Information
2018-12-14 French
THERANEXUS ANNOUNCES APPOINTMENT OF JEROME MARTINEZ TO ITS BOARD OF DIRECTORS
Board/Management Information
2018-12-14 English
THERANEXUS ANNOUNCES THE PUBLICATION OF A SCIENTIFIC ARTICLE ON THE MECHANISM OF ACTION OF DRUG CANDIDATE THN102 IN THE INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Regulatory Filings
2018-05-22 English
THERANEXUS ANNONCE LA PUBLICATION D'UN ARTICLE SCIENTIFIQUE SUR LE MECANISME D'ACTION DU CANDIDAT MEDICAMENT THN102 DANS LA REVUE ' INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY '
Regulatory Filings
2018-05-22 French
THERANEXUS PUBLISHES ITS CASH POSITION AS AT 31 MARCH 2018
Net Asset Value
2018-05-15 English
THERANEXUS PUBLIE SA POSITION DE TRESORERIE AU 31 MARS 2018
Capital/Financing Update
2018-05-15 French
Theranexus presentation at the International Connexins Symposium (Vancouver 14-15 May 2018)
Investor Presentation
2018-05-07 English
Présentation de THERANEXUS au Symposium international sur les connexines (Vancouver 14-15 mai 2018)
Regulatory Filings
2018-05-07 French
ORAL PRESENTATION OF THERANEXUS AT THE 9TH EUROPEAN CONGRESS ON NARCOLEPSY 5 AND 6 MAY IN MONTPELLIER
Regulatory Filings
2018-05-02 English
PRÉSENTATION ORALE DE THERANEXUS LORS DU 9ÈME CONGRÈS EUROPÉEN SUR LA NARCOLEPSIE LES 5 ET 6 MAI À MONTPELLIER
AGM Information
2018-05-02 French
MISE À DISPOSITION DU DOCUMENT DE RÉFÉRENCE 2017
Report Publication Announcement
2018-04-27 French
THN102 OBTAINS INVESTIGATIONAL NEW DRUG STATUS FROM THE FOOD AND DRUG ADMINISTRATION (FDA)
Regulatory Filings
2018-04-23 English
LE THN102 OBTIENT LE STATUT D'INVESTIGATIONAL NEW DRUG DE LA FOOD AND DRUG ADMINISTRATION (FDA)
Regulatory Filings
2018-04-23 French
THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL WITH THN 102 IN PARKINSON'S DISEASE PATIENTS
Regulatory Filings
2018-04-19 English
THERANEXUS ANNONCE L'OBTENTION D'UNE PREMIERE AUTORISATION EUROPEENNE POUR L'ETUDE CLINIQUE DE PHASE 2 AVEC THN102 DANS LA MALADIE DE PARKINSON
Regulatory Filings
2018-04-19 French
THERANEXUS ANNOUNCES A SUCCESSFUL CLINICAL PHARMACOKINETIC STUDY AS PART OF THE DEVELOPMENT OF ITS DRUG CANDIDATES THN201 AND THN101
Regulatory Filings
2018-03-21 English
THERANEXUS ANNONCE LE FRANCHISSEMENT D'UNE ETAPE DE PHARMACOCINETIQUE CLINIQUE DANS LE CADRE DU DEVELOPPEMENT DE SES CANDIDATS MEDICAMENTS THN201 ET THN101
Regulatory Filings
2018-03-21 French
THERANEXUS AND THE COLLEGE DE FRANCE SIGN A RESEARCH AGREEMENT ON ASTROCYTE-NEURON INTERACTIONS
Regulatory Filings
2018-03-15 English
THERANEXUS ET LE COLLEGE DE FRANCE SIGNENT UNE COLLABORATION DE RECHERCHE SUR LES INTERACTIONS ASTROCYTES-NEURONES
Regulatory Filings
2018-03-15 French
THERANEXUS PUBLIE SON AGENDA FINANCIER 2018
Report Publication Announcement
2018-01-29 French
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE - 2ND SEMESTRE 2017
Capital/Financing Update
2018-01-17 French